Subclassifications Of Assets, Liabilities And Equities [Abstract]

Innate Pharma - Filing #2821023

Concept	As at 2020-12-31	As at 2019-12-31	As at 2018-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	11 694 EUR	11 672 EUR	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	46 289 EUR	96 968 EUR	—
Trade and other non-current receivables [abstract]
Trade and other non-current receivables	29 821 EUR	16 737 EUR	—
Trade and other current receivables [abstract]
Trade and other current receivables	21 814 EUR	18 740 EUR	—
Trade and other receivables [abstract]
Trade and other receivables	51 635 EUR	28 716 EUR	139 012 EUR
Categories of non-current financial assets [abstract]
Non-current financial assets	38 934 EUR	37 005 EUR	—
Categories of current financial assets [abstract]
Current financial assets	14 845 EUR	15 978 EUR	—
Cash and cash equivalents [abstract]
Cash and cash equivalents	136 792 EUR	202 887 EUR	152 314 EUR
Trade and other current payables [abstract]
Trade and other current payables	29 539 EUR	49 504 EUR	—
Trade and other payables [abstract]
Trade and other payables	29 519 EUR	36 047 EUR	34 662 EUR
Categories of non-current financial liabilities [abstract]
Non-current financial liabilities	16 945 EUR	16 593 EUR	—
Categories of current financial liabilities [abstract]
Current financial liabilities	2 142 EUR	2 130 EUR	—
Issued capital [abstract]
Issued capital	3 950 EUR	3 941 EUR	—
Net assets (liabilities) [abstract]
Assets	307 423 EUR	401 361 EUR	—
Net current assets (liabilities) [abstract]
Current assets	173 451 EUR	237 605 EUR	—
Current liabilities	45 488 EUR	121 822 EUR	—
Assets less current liabilities [abstract]